search
stem cell therapy
Trends
- 1South Korean Stem-Cell Firm MEDIPOST Eyes Global Regenerative Medicine Growth▼MEDIPOST: From Korea’s Stem-Cell Pioneer to Global Regenerative Medicine Leader
MEDIPOST, a South Korean biotechnology company, is being profiled for its evolution from a domestic stem-cell therapy pioneer into an aspiring global player in regenerative medicine. The company is known for developing cell-based treatments, including therapies derived from umbilical cord blood stem cells, and is now looking to expand its international footprint in a fast-growing field of medicine.
- 2CAR-T vs Stem Cell Transplant: What's Next in 2026▼CAR-T vs Stem Cell Transplantation: Where Are Practice and Science Heading in 2026?
Medical experts are weighing CAR-T cell therapy against stem cell transplantation as treatment standards for blood cancers evolve into 2026. The debate centres on which approach should come first for patients, how access and cost shape practice, and what emerging clinical evidence says about combining or sequencing the two therapies in coming years.